Aisling Capital Partners III LP, 10% Owner, Director at Loxo Oncology, Inc. (LOXO), bought 160,000 shares at $31.00 ($5.0M) on 2017-01-10, disclosed to the SEC on 2017-01-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| VSAR | BUY | 2014-03-27 | $1.3M | — | Filing → |
| ZLTQ | SELL | 2013-11-15 | $7.0M | — | Filing → |